Literature DB >> 35871003

Monkeypox claims new victims: the outbreak in men who have sex with men.

Xiaoning Liu1,2, Zheng Zhu3,4,5, Yun He1, Jia Wen Lim2, Bethany Lane2,6, Hui Wang1, Qiaoli Peng1, Liqin Sun1, Hongzhou Lu7.   

Abstract

Monkeypox has a very prominent regional epidemic. It has been confined to Western and Central African countries. Sporadic cases found in countries outside Africa generally have a history of sojourn in endemic areas. However, the recent multinational outbreak of monkeypox cases in Europe in early May 2022 has revealed a changing epidemiological trend, those confirmed cases had no sojourn history in endemic areas and with a high proportion of cases involving men who have sex with men (MSM). Among the MSM cases, many of them presented atypical clinical manifestations of monkeypox and with other sexually transmitted diseases co-infection. Combined with the high social interactivity in this community, there is likely a higher risk of monkeypox transmission in this population. Establishing an infectious disease surveillance system, maintaining highly vigilant regarding the transmission of monkeypox in MSM, and responding promptly are necessary and effective measures to contain the outbreak.
© 2022. The Author(s).

Entities:  

Keywords:  Infectious diseases; Men have sex with men; Monkeypox; Public health

Mesh:

Year:  2022        PMID: 35871003      PMCID: PMC9308177          DOI: 10.1186/s40249-022-01007-6

Source DB:  PubMed          Journal:  Infect Dis Poverty        ISSN: 2049-9957            Impact factor:   10.485


Background

Monkeypox is a zoonotic disease caused by the monkeypox virus. With the eradication of smallpox in 1980 and subsequent discontinuation of the smallpox vaccination, monkeypox is emerging as the most significant pox virus affecting public health at present. Since the first human case was discovered in 1970, the disease has been confined to Western and Central Africa. However, since 2003, sporadic cases have been detected in countries outside of Africa, though these usually coincide with a history of exposure in endemic areas [1]. The recent multinational outbreak of monkeypox cases in Europe around the beginning of May 2022 has revealed a changing epidemiological trend [2]. As of June 22, 3413 confirmed cases have been reported in fifty countries and the number of cases is still rising [3]. These cases had no sojourn history in endemic areas and with a high proportion of cases involving men who have sex with men (MSM). Despite the fact that monkeypox virus was recently detected in the semen of confirmed cases in Italy, potential contamination of the specimens should be considered [4]. There is still no high-quality evidence that monkeypox can be transmitted sexually, highlighting a research gap that remains to be filled.

Monkeypox characteristics in MSMs

Interestingly, many confirmed monkeypox cases in the MSM population do not exhibit the classic clinical manifestations. The most notable features are genital and perianal rashes, which often appear as the first symptoms. Furthermore, the morphology of the rash does not progress from maculopapular rash to blisters and pustules as in typical cases, instead, pustules have appeared before systemic symptoms (e.g., fever) in some cases [4-6]. The initial appearance of genital or perianal rash may imply that close physical contact during sexual intercourse acts as a possible transmission route. All reported cases of monkeypox in MSM had sexual exposure with or without using condoms prior to symptom onset [5, 6]. It is unclear whether condom use has a protective effect on monkeypox transmission. However, condom use is still strongly recommended to prevent other sexually transmitted diseases (STDs). Reported monkeypox cases in MSM include both HIV-positive cases with viral suppression and HIV-negative cases receiving pre-exposure prophylaxis, and many are diagnosed alongside other STDs. Coinfection with hepatitis A, B, or C is also common [4-8]. Detailed data on HIV and other STDs co-infection in confirmed cases is still absent. The World Health Organization (WHO) has subsequently developed a monkeypox case reporting form to capture this crucial information [9]. It is hoped that this data will improve understanding on the characteristics of MSM with monkeypox, to aid future prevention and treatment.

Health threat of monkeypox in MSMs

Monkeypox is ordinarily a self-limiting disease. Clinical outcomes are related to the degree of viral exposure, patient's health status, and the nature of complications. Immunodeficiency, such as advanced or uncontrolled HIV infection may lead to more severe clinical manifestations. Since HIV patients usually have multiple comorbidities, such as hepatitis, tuberculosis, and/or other STDs, this can cause additional complications and complicate treatment. In addition, due to similarities in the presentations of the monkeypox rash and some STDs, misdiagnosis may be more common in the MSM population than in the general population. It was reported that some cases were misdiagnosed as herpes simplex virus (HSV) or varicella-zoster virus (VZV) infection in this outbreak [5], resulting in late detection and management, thus increasing the risk of community transmission. Furthermore, the high social interactivity in MSM contributes to a high risk of monkeypox transmission in this population.

Recommendations for the management of monkeypox in MSMs

A well-developed infectious disease surveillance system facilitates early detection of diseases and contact tracing. Some countries, such as United Kingdom and the Republic of Korea, have listed monkeypox as a statutory notifiable disease. Healthcare workers should be highly vigilant about monkeypox transmission in MSM. It is necessary to consider the diagnosis of monkeypox in MSM patients with a typical rash and risky sexual behaviour, especially in those with a history of sexual contact at the site of the disease outbreak. Patients having a sexual history in MSM should be actively screened for HIV and other STD infections. For those with HIV co-infection, antiretroviral therapy and viral load monitoring should be provided as an urgent public health priority. Finally, although current monkeypox outbreaks are mainly in the MSM populations, it is crucial to avoid stigmatisation. Effective communication and community engagement are paramount to ending the monkeypox outbreak.

Conclusions

The emerging monkeypox outbreak in non-endemic areas featured by absence of sojourn history in endemic areas and high proportion of MSMs, has garnered international interest. There is currently no high-quality evidence that monkeypox can be transmitted sexually, exposing an unfilled research gap. The WHO has announced great concern over the progress of the outbreak. Establishing an infectious disease surveillance system, maintaining highly vigilant regarding the transmission of monkeypox in MSM, and intervening early are necessary and effective measures to contain the outbreak.
  7 in total

1.  Monkeypox outbreak in Europe, UK, North America, and Australia: A changing trend of a zoonotic disease.

Authors:  Beatriz Cabanillas; Rafael Valdelvira; Cezmi A Akdis
Journal:  Allergy       Date:  2022-08       Impact factor: 14.710

2.  Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022.

Authors:  Andrea Antinori; Valentina Mazzotta; Serena Vita; Fabrizio Carletti; Danilo Tacconi; Laura Emma Lapini; Alessandra D'Abramo; Stefania Cicalini; Daniele Lapa; Silvia Pittalis; Vincenzo Puro; Marco Rivano Capparuccia; Emanuela Giombini; Cesare Ernesto Maria Gruber; Anna Rosa Garbuglia; Alessandra Marani; Francesco Vairo; Enrico Girardi; Francesco Vaia; Emanuele Nicastri
Journal:  Euro Surveill       Date:  2022-06

3.  Monkeypox infection presenting as genital rash, Australia, May 2022.

Authors:  Yael Hammerschlag; Gina MacLeod; Georgina Papadakis; Asiel Adan Sanchez; Julian Druce; George Taiaroa; Ivana Savic; Jamie Mumford; Jason Roberts; Leon Caly; Deborah Friedman; Deborah A Williamson; Allen C Cheng; James H McMahon
Journal:  Euro Surveill       Date:  2022-06

4.  The changing epidemiology of human monkeypox-A potential threat? A systematic review.

Authors:  Eveline M Bunge; Bernard Hoet; Liddy Chen; Florian Lienert; Heinz Weidenthaler; Lorraine R Baer; Robert Steffen
Journal:  PLoS Negl Trop Dis       Date:  2022-02-11

5.  Monkeypox in Europe and beyond - tackling a neglected disease together.

Authors:  Hans Kluge; Andrea Ammon
Journal:  Euro Surveill       Date:  2022-06

6.  Transmission of monkeypox virus through sexual contact - A novel route of infection.

Authors:  Joseph Heskin; Amy Belfield; Charlotte Milne; Nicklas Brown; Yasmin Walters; Christopher Scott; Margherita Bracchi; Luke Sp Moore; Nabeela Mughal; Tommy Rampling; Alan Winston; Mark Nelson; Sarah Duncan; Rachael Jones; D Ashley Price; Borja Mora-Peris
Journal:  J Infect       Date:  2022-06-01       Impact factor: 38.637

7.  Coinfection of syphilis and monkeypox in HIV positive man in Prague, Czech Republic.

Authors:  Beatrice Bížová; Dan Veselý; Milan Trojánek; Filip Rob
Journal:  Travel Med Infect Dis       Date:  2022-06-02       Impact factor: 20.441

  7 in total
  6 in total

1.  Sexually-transmitted monkeypox: report of two cases.

Authors:  Paula Sian Lopes; Gabriela Roncada Haddad; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2022-09-20       Impact factor: 2.113

2.  Monkeypox virus crosstalk with HIV; where do we stand now?

Authors:  Maryam Shafaati; Milad Zandi; Om Prakash Choudhary
Journal:  Int J Surg       Date:  2022-09-09       Impact factor: 13.400

3.  Bibliometric analysis of human monkeypox research from 1975 to 2022 and novel prevention and control strategies.

Authors:  Jiyong Lin; Guiyu Li; Peiling Zhong; Qiang Zeng; Lei Liu; Liang Chen
Journal:  Front Public Health       Date:  2022-09-27

4.  Monkeypox Virus Infections in Southern Italy: Is There a Risk for Community Spread?

Authors:  Daniela Loconsole; Anna Sallustio; Francesca Centrone; Daniele Casulli; Marisa Accogli; Annalisa Saracino; Caterina Foti; Mauro Grandolfo; Giovanni Battista Buccoliero; Viviana Vitale; Sara De Nitto; Michele Conversano; Francesco Desiante; Laura Del Sambro; Domenico Simone; Antonio Parisi; Rosa Prato; Domenico Martinelli; Maria Chironna
Journal:  Int J Environ Res Public Health       Date:  2022-09-17       Impact factor: 4.614

5.  Combating Stigma and Health Inequality of Monkeypox: Experience from HIV.

Authors:  Zhongfang Yang; Xiaoning Liu; Zheng Zhu; Lin Zhang; Shuyu Han; Yanfen Fu; Hongzhou Lu
Journal:  Infect Drug Resist       Date:  2022-10-14       Impact factor: 4.177

6.  Re: action to prevent monkeypox in Iran: special attention to men who have sex with men.

Authors:  Amir Kabir; Irwin Nazaret
Journal:  Clin Microbiol Infect       Date:  2022-09-20       Impact factor: 13.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.